Infectious Disorders - Drug Targets
(Formerly 'Current Drug Targets - Infectious Disorders')

ISSN: 1871-5265 - Volume 8, 4 Issues, 2008

Editor-in-Chief

Babu L Tekwani, Ph.D.
Senior Scientist II
National Center for Natural Products Research
School of Pharmacy
University of Mississippi
University MS 38677
Phone- 662-915-7882
Fax- 662-915-7062
Email- btekwani@Olemiss.edu

Editorial Advisory Board:

C. Abad-Zapatero (Abbott Lab., Abbott Park, IL, USA)
A.K. Agrawal (PolyMASC Pharm Plc., London)
D. Andreotti (GlaxoSmithkline Res. Centre, Verona, Italy)
J.L. Blanchard (Univ. Massachusetts, Amherst, MA, USA)
A. Branstrom (PTC Therapeutics, South Plainfield, NJ, USA)
Y. Cheng (Yale Univ., New Haven, CT, USA)
W.S. Champney (J.H. Quillen College of Medicine, East Tennessee State University ,TN, USA)
P.M. Colman (The Walter and Eliza Hall Inst., Melbourne, Victoria, Australia)
P. Courvalin (Inst. Pasteur, Paris, France)
H.L. Davis (Coley Pharm. Group, Ottawa, ON, Ontario, Canada)
E.De Clercq (Rega Inst., K.U. Leuven, Belgium)
F. Doucet-Populaire (Univ. Paris, Paris, France)
B. Finlay (Univ. British Colombia, Vancouver, BC, B.C., Canada)
O. Golubnitschaja (Friedrich-Wilhelms, Univ. of Bonn, Germany)
N.A.R. Gow (Univ. Aberdeen, Aberdeen, UK)
G. Gregoriadis (Univ. London, London, UK)
S. Ilyin (Johnson & Johnson Pharm Res and Dev., Spring House, PA, USA)
Kuan-T Jeang (Nat. Inst. Health, Bethesda, MD, USA)
D. Kahne (Harvard Univ., Boston, MA, NJ, USA)
W.M. Kazmierski (GlaxoSmithKline Res. & Develop., NC, USA)
W. Kohlbrenner (Abbott Lab., Abbott Park, IL, IL, USA)
S. Lory (Harvard Univ., Boston, MA, MA, USA)
B.C. Monk (Univ. Otago, Dunedin, New Zealand)
B.E. Murray (Univ. of Texas, Huston, TX, USA)
R.N. Ondarza (Nat. Inst. Public Health, Mexico)
M.C. O'Sullivan (Canisius College, Buffulo, NY, NY, USA)
J. Pace (Protez Pharmaceuticals, Melvern, PA, USA)
M. Preobrazhenskaya (Gause Inst. Of New Antibiotics, Moscow, Russia)
F. Scaglione (Univ. Milan, Milan, Italy)
M.E. Selsted (Univ. California, Irvine, CA , USA)
I. Shinkai (Mitsui & Co. Ltd., Tokoyo, Tokyo, JAPAN)
M.J. Sofia (Pharmasset, Inc., Princeton, NJ, USA)
G.G. Stone( Pfizer Global Research and Development, Groton, USA)
T.J. Trust (AstraZeneca, Waltham, MA, MA, USA)
B. Wilkenson ( Illinois State University, Normal, IL,USA)
T. Wood (Pfizer Global Research and Development, Kent UK)